Skip to main content
SpringerLink
Log in

Inhibitors of leukotrienes: An overview

  • Chapter
Novel Inhibitors of Leukotrienes

Part of the book series: Progress in Inflammation Research ((PIR))

  • 88 Accesses

Abstract

The steps that have led to the isolation, structural elucidation and chemical synthesis, and investigations into the biological properties of the arachidonic acid metabolites undoubtedly represent one of the most crucial developments in our understanding of the mechanisms that are intimately involved in inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kurzrok R, Lieb CC (1930) Biochemical studies of human semen. II. The action of semen on the human uterus. Proc Soc Exp Biol Med 28: 268–272

    Google Scholar 

  2. Feldberg W, Kellaway CH (1938) Liberation of histamine and formation of lysocithin-like substances by cobra venom. J Physiol 94: 187–226

    PubMed  CAS  Google Scholar 

  3. Brockelhurst WE (1960) The release of histamine and formation of a slow-reacting sub-stance (SRS-A) during anaphylactic shock. J Physiol 151: 416–435

    Google Scholar 

  4. Murphy RC, Hammarstrom S, Samuelsson B (1979) Leukotriene C: A slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci USA 76: 4275–4279

    Article  PubMed  CAS  Google Scholar 

  5. Samuelsson B (1997) The discovery of the leukotrienes and the structure elucidation of SRA-A. In: S Holgate, SE Dahlen (eds): SRS-A to leukotrienes: The dawning of a new treatment. Blackwell Science, London, 39–49

    Google Scholar 

  6. Fitzimmons BJ, Rokach J (1989) The development of the new anti-leukotriene drugs: specific LTD4 antagonists and 5-LO inhibitors. In: J Rokach (ed): Leukotrienes and lipoxygenases. Elsevier, Amsterdam, 427–502

    Google Scholar 

  7. Batt DG (1992) 5-lipoxygenase inhibitors and their antiinflammatory activities. In: GP Ellis, DK Luscombe (eds): Progress in medicinal chemistry. Elsevier, Amsterdam, 1–63

    Google Scholar 

  8. O’Byrne PM, Israel E, Drazen J (1997) Antileukotrienes in the treatment of asthma. Ann Intern Med 127: 472–480

    PubMed  Google Scholar 

  9. Spector SL (1997) Leukotriene activity modulation in asthma. Drugs 54 (3): 369–384

    Article  PubMed  CAS  Google Scholar 

  10. Brock TG, McNish RW, Peters-Golden M (1995) Translocation of leukotriene synthet-is capacity of nuclear 5-lipoxygenase in rat basophilic leukemia cells and alveolar macrophages. J Biol Chem 270: 21652–21658

    Article  PubMed  CAS  Google Scholar 

  11. Coleman RA, Smith WL, Narumiya S (1994) Classification of prostanoid receptors: properties, distribution and structure of the receptors and their subtypes. Pharmacol Rev 46: 205–229

    PubMed  CAS  Google Scholar 

  12. Yokomizo T, Izumi T, Chang K, Takuwa Y, Shimizu T (1997) A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 387: 620–624

    Article  PubMed  CAS  Google Scholar 

  13. Nicosia S, Capra V, Accomazzo MR, Galbiati E, Ragnini D, Saponara R, Novarini S, Rovati E (1996) Receptors and second messengers for cys-leukotrienes. In: GC Folco, B Samuelsson, J Maclouf, GP Velo (eds): Eicosanoids: from biotechnology to therapeutic applications. Plenum Press, New York, 127–136

    Google Scholar 

  14. Dahlen SE, Hedqvist P, Hammarstrom S, Samuelsson B (1980) Leukotrienes are potent constrictors of human bronchi. Nature 288: 484–486

    Article  PubMed  CAS  Google Scholar 

  15. Lewis RA, Austen KF, Soberman RJ (1990) Leukotrienes and other products of the 5lipoxygenase pathway — biochemistry and relation to pathobiology in human diseases. N Engl J Med 323: 645–655

    Article  PubMed  CAS  Google Scholar 

  16. Marom Z, Shelhamer JH, Bach MK, Morton DR, Kaliner M (1982) Slow-reacting substances, leukotriene C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis 126: 449–451

    CAS  Google Scholar 

  17. Sautebin L, Viganò T, Grassi E, Crivellari MT, Galli G, Berti F, Mezzetti M, Folco GC (1985) Release of leukotrienes, induced by the Ca-ionophore A23187, from human lung parenchyma in vitro. J Pharmacol Exp Therap 243: 217–221

    Google Scholar 

  18. Weller PF, Lee CW, Foster D, Corey EJ, Austen KF (1983) Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. Proc Natl Acad Sci USA 80: 7626–7630

    Article  PubMed  CAS  Google Scholar 

  19. Peters SP, MacGlashan DW, Schulman ES, Schleimer RP, Hayes EC, Rokach J, Adkinson NF, Lichtenstein LM (1984) Arachidonic acid metabolism in purified human lung mast cells. J Immunol 132: 1972–1979

    PubMed  CAS  Google Scholar 

  20. Miadonna A, Tedeschi A, Brasca C, Folco GC, Sala A, Murphy RC (1990) Mediator release after endobronchial antigen challenge in patients with respiratory allergy. J Allergy Clin Immunol 85: 906–913

    Article  PubMed  CAS  Google Scholar 

  21. Sestini P, Armetti L, Gambaro G, Pieroni MG, Refini RM, Sala A, Vaghi A, Folco GC, Bianco S, Robuschi M (1996) Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 153: 572–575

    CAS  Google Scholar 

  22. Cloud ML, Enas GC, Kemp J (1989) A specific LTD4/LTE4 receptor antagonist improves pulmonary function in patients with mild chronic asthma. Am Rev Respir Dis 140: 1336–1339

    Article  PubMed  CAS  Google Scholar 

  23. Sharon P, Stenson WF (1984) Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 86: 453–460

    PubMed  CAS  Google Scholar 

  24. Dreyling KW, Kozuschek W, Schaarschmidt K, Goebell H, Peskar BM (1987) Role of the endogenous leukotriene system in chronic inflammatory bowel disease. Prog Clin Biol Res 242: 309–315

    PubMed  CAS  Google Scholar 

  25. Bonnet C, Bertin P, cook-Moreau J, Chable-Rabinovitch H, Treves R, Rigaud M (1995) Lipoxygenase products and expression of 5-lipoxygenase and FLAP in human cultured synovial cells. Prostaglandins 50 (3): 127–135

    Article  PubMed  CAS  Google Scholar 

  26. Griffiths RG, Pettipher ER, Koch K, Farrell CA, Breslow R, Conklyn MJ, Smith MA, Hackman BC, Wimberly DJ, Milici AJ (1995) Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis. Proc Natl Acad Sci USA 92 (2): 517–521

    Article  PubMed  Google Scholar 

  27. Lauritsen K, Laursen LS, Burhavc K, Rask-Madsen J (1986) Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology 91: 837–844

    PubMed  CAS  Google Scholar 

  28. Letts LG (1987) Leukotrienes: role in cardiovascular physiology. Cardiovascular Clinics 18 (1): 101–113

    PubMed  CAS  Google Scholar 

  29. Lefer AM (1988) Thromboxane A2 and leukotrienes are eicosanoid mediators of shock and ischemic disorders. Prog Clin Biol Res 264: 101–114

    PubMed  CAS  Google Scholar 

  30. Vigorito C, Giordano A, Cirillo R, Genovese A, Rengo F, Marone G (1997) Metabolic and hemodynamic effects of peptide leukotriene C4 and D4 in man. Int J Clin Lab Res 27 (3): 178–184

    Article  PubMed  CAS  Google Scholar 

  31. Marone G, deCrescenzo G, Adt M, Patella V, Arbustini E, Genovese A (1995) Immunological characterization and functional importance of human heart mast cells. Immunopharmacology 31 (1): 1–18

    Article  PubMed  CAS  Google Scholar 

  32. Carry M, Korley V, Willerson JT, Weigelt JT, Ford-Hutchinson AW, Tagari P (1992) Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation. Circulation 85: 230–236

    Article  PubMed  CAS  Google Scholar 

  33. Scoggan KA, Jakobsson PJ, Ford-Hutchinson AW (1997) Production of leukotriene C4 in different human tissues is attributable to distinct membrane bound biosynthetic enzymes. J Biol Chem 272 (15): 10182–10187

    Article  PubMed  CAS  Google Scholar 

  34. Hashimoto H, Miyazawa K, Hagiwara M, Miyasaka K, Nakashima M (1990) Beneficial effects of a new 5-lipoxygenase inhibitor on occlusion and occlusion-reperfusioninduced myocardial injury. Arzneim Forsch Drug Res 40: 126–129

    CAS  Google Scholar 

  35. Sasaki K, Ueno A, Kawamura M, Katori M, Shigehiro S, Kikawada R (1987) Reduction of myocardial infarct size in rats bby a selective 5-LO inhibitor (AA-861). Adv Prostaglandin Thromboxane Leukot Res 17: 381–383

    Google Scholar 

  36. Amsterdam EA, Pan HL, Rendig SV, Symons JD, Fletcher MP, Longhurst JC (1993) Limitation of myocardial infarct size in pigs with a dual lipoxygenase-cyclooxygenase blocking agent by inhibition of neutrophil activity without reduction of neutrophil migration. J Am Coll Cardiol 22: 1738–1744

    Article  CAS  Google Scholar 

  37. Toki Y, Hieda N, Torii T, Hashimoto H, Ito T, Ogawa K, Satake T (1988) The effect of lipoxygcnase inhibitor and peptidoleukotriene antagonist on myocardial injury in a canine coronary occlusion-reperfusion model. Prostaglandins 35(4): 555–571

    Article  PubMed  CAS  Google Scholar 

  38. Mullane K, Hatala MA, Kraemer R, Sessa W, Westlin W (1987) Myocardial salvage induced by REV-5901: an inhibitor and antagonist of the leukotrienes. J Cardiovasc Pharmacol 10 (4): 398–406

    Article  PubMed  CAS  Google Scholar 

  39. Rossoni G, Sala A, Berti F, Testa T, Buccellati C, Müller-Peddinghaus R, Maclouf J, Folco GC (1996) Myocardial protection by the leukotriene synthesis inhibitor BAY X 1005: importance of transcellular biosynthesis of cysteinyl-leukotrienes. J Pharmacol Exp Therap 276: 335–341

    CAS  Google Scholar 

  40. Hahn RA, MacDonald BR, Simpson PJ, Wang L, Towner RD, Ho PP, Goodwin M, Breau AP, Suarez T, Mihelic ED (1991) Characterization of LY233569 on 5-LO and reperfusion injury of ischemic myocardium. J Pharmacol Exp Ther 256 (1): 94–102

    PubMed  CAS  Google Scholar 

  41. Hock CE, Beck LD, Papa LA (1992) Peptide leukotriene receptor antagonism in myocardial ischemia and reperfusion. Cardiovascular Res 26 (12): 1206–1211

    Article  CAS  Google Scholar 

  42. Ito BR, Roth DM, Engler RL (1990) Thromboxane A2 and peptidoleukotrienes contribute to the myocardial ischemia and contractile dysfunction in response to intracoronary infusion of complement C5a in pigs. Circulation Res 66 (3): 596–607

    Article  PubMed  CAS  Google Scholar 

  43. Ito T, Toki Y, Hieda N, Okumura K, Hashimoto H, Ogawa K, Satake T (1989) Protective effects of a thromboxane synthetase inhibitor, a thromboxane antagonist, a lipoxygenase inhibitor and a leukotriene C4, D4 antagonist on myocardial injury caused by acute myocardial infarction in the canine heart. Jpn Circ J 53 (9): 1115–1121

    Article  PubMed  CAS  Google Scholar 

  44. Hahn RA, MacDonald BR, Morgan E, Potts BD, Parli CJ, Rinkema LE, Whitesitt CA, Marshall WS (1992) Evaluation of LY203647 on cardiovascular leukotriene D4 receptors and myocardial reperfusion injury. J Pharmacol Exper Ther 260: 979–989

    CAS  Google Scholar 

  45. Hahn RA, MacDonald BR, Simpson PJ, Potts BD, Parli CJ (1990) Antagonism of leukotriene B4 receptors does not limit canine myocardial infarct size. J Pharmacol Exper Ther 253: 58–66

    CAS  Google Scholar 

  46. Egan JW, Griswold DE, Hillegass LM, Newton JF, Eckardt RD, Slivjak MJ, Smith EF (1989) Selective antagonism of peptidoleukotriene responses does not reduce myocardial damage or neutrophil accumulation following coronary artery occlusion with reperfusion. Prostaglandins 37 (5): 597–613

    Article  PubMed  CAS  Google Scholar 

  47. Allen SP, Sampson AP, Piper PJ, Chester AH, Ohri SK, Yacoub MH (1993) Enhanced excretion of urinary LTE4 in coronary artery disease and after coronary artery bypass surgery. Coron Artery Dis 4 (10): 899–904

    Article  PubMed  CAS  Google Scholar 

  48. Roberts WG, Simon TJ, Berlin RG, Haggitt RC, Snyder ES, Stenson WF, Hanauer SB, Reagan JE, Cagliola A, Tanaka WK et al (1997) Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591. Gastroenterology 112: 725–732

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Cardiopulmonary Pharmacology, Institute of Pharmacological Sciences, School of Pharmacy, University of Milan, via Balzaretti 9, Milan, 20133, Italy

    Giancarlo Folco

Authors
  1. Giancarlo Folco
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Center for Cardiopulmonary Pharmacology Institute of Pharmacological Sciences, University of Milan, Via Balzaretti 9, Milan, 20133, Italy

    Giancarlo Folco

  2. Department of Medical Biochemistry and Biophysics Division of Physiological Chemistry II, Karolinska Institute, Stockholm, 10401, Sweden

    Bengt Samuelsson

  3. National Jewish Medical and Research Center, 1400 Jackson St., Denver, CO, 80206, USA

    Robert C. Murphy

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Basel AG

About this chapter

Cite this chapter

Folco, G. (1999). Inhibitors of leukotrienes: An overview. In: Folco, G., Samuelsson, B., Murphy, R.C. (eds) Novel Inhibitors of Leukotrienes. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8703-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8703-8_14

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9736-5

  • Online ISBN: 978-3-0348-8703-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation